In vitro and in vivo antidiabetic potential of extracts and a furostanol saponin from Balanites aegyptiaca

References

• Abdel Motaal A, El-Askary H, Crockett S, Kunert O, Sakr B, Shaker S, Grigore A, Albulescu R, Bauer R. 2015. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca. Phytomedicine. 22:829–836.
   PubMed Web of Science ®Google Scholar
• Agrawal PK, Jain DC, Gupta RK, Thakur RS. 1985. Carbon-13 NMR spectroscopy of steroidal sapogenins and steroidal saponins. Phytochemistry. 24:2479–2496.
   Web of Science ®Google Scholar
• Brosky G, Logothetopoulos J. 1969. Streptozotocin diabetes in the mouse and Guinea pig. Diabetes. 18:606–611.
   PubMed Web of Science ®Google Scholar
• Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. 1974. Enzymatic determination of total serum cholesterol. Clin Chem. 20:470–475.
   PubMed Web of Science ®Google Scholar
• Campbell LK, White JR, Campbell RK. 1996. Acarbose: its role in the treatment of diabetes mellitus. Ann Pharmacother. 30:1255–1262.
   PubMed Web of Science ®Google Scholar
• Cheyne GA, Gilmore EA. 1973. Stability of the blood glucose colour complex with 4-aminophenazone as oxygen acceptor. Med Lab Technol. 30:191–192.
   PubMedGoogle Scholar
• Chothani DL, Vaghasiya HU. 2011. A review on Balanites aegyptiaca Del (desert date): phytochemical constituents, traditional uses, and pharmacological activity. Phcog Rev. 5:55–62.
   Google Scholar
• Fossati P, Prencipe L. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 28:2077–2080.
   PubMed Web of Science ®Google Scholar
• Guzmán Á, Guerrero RO. 2005. Inhibition of aldose reductase by herbs extracts and natural substances and their role in prevention of cataracts. Rev Cubana Plant Med. 10:3–4.
   Google Scholar
• Hara S, Okabe H, Mihashi K. 1987. Gas-liquid chromatographic separation of aldose enantiomers as trimethylsilyl ethers of methyl 2-(polyhydroxyalkyl)-thiazolidine-4(R)-carboxylates. Chem Pharm Bull. 35:501–506.
   Web of Science ®Google Scholar
• Hosny M, Khalifa T, Calis I, Wright AD, Sticher O. 1992. Balanitoside, a furostanol glycoside, and 6-methyldiosgenin from Balanites aegyptiaca. Phytochemistry. 31:3565–3569.
   PubMed Web of Science ®Google Scholar
• Jackson JE, Bressler R. 1981. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1. Drugs. 22:211–245.
   PubMed Web of Science ®Google Scholar
• Juárez-Rojop IE, Díaz-Zagoya JC, Ble-Castillo JL, Miranda-Osorio PH, Castell-Rodríguez AE, Tovilla-Zárate CA, Rodríguez-Hernández A, Aguilar-Mariscal H, Ramón-Frías T, Bermúdez-Ocaña DY. 2012. Hypoglycemic effect of Carica papaya leaves in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 12:236.
   PubMed Web of Science ®Google Scholar
• Judzewitsch RG, Pfeifer MA, Best JD, Beard JC, Halter JB, Porte D Jr. 1982. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. J Clin Endocrinol Metab. 55:321–328.
   PubMed Web of Science ®Google Scholar
• Kamel MS. 1998. A furostanol saponin from fruits of Balanites aegyptiaca. Phytochemistry. 48:755–757.
   PubMed Web of Science ®Google Scholar
• Kamel MS, Koskinen A. 1995. Pregnane glycosides from fruits of Balanites aegyptiaca. Phytochemistry. 40:1773–1775.
   PubMed Web of Science ®Google Scholar
• King AJ. 2012. The use of animal models in diabetes research. Br J Pharmacol. 166:877–894.
   PubMed Web of Science ®Google Scholar
• Li H, Song F, Xing J, Tsao R, Liu Z, Liu S. 2009. Screening and structural characterization of α-glucosidase inhibitors from Hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS. J Am Soc Mass Spectrom. 20:1496–1503.
   PubMed Web of Science ®Google Scholar
• Matsui T, Tanaka T, Tamura S, Toshima A, Tamaya K, Miyata Y, Tanaka K, Matsumoto K. 2007. alpha-Glucosidase inhibitory profile of catechins and theaflavins. J Agric Food Chem. 55:99–105.
   PubMed Web of Science ®Google Scholar
• Motaal AA, Shaker S, Haddad PS. 2012. Antidiabetic activity of standardized extracts of Balanites aegyptiaca fruits using cell-based bioassays. Phcog J. 4:20–24.
   Google Scholar
• Murugan P, Pari L. 2006. Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin–nicotinamide-induced diabetic rats. Basic Clin Pharmacol Toxicol. 99:122–127.
   PubMed Web of Science ®Google Scholar
• Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. 1991. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta. 1078:171–178.
   PubMed Web of Science ®Google Scholar
• Patel MB, Mishra SM. 2009. Aldose reductase inhibitory activity of a C-glycosidic flavonoid derived from Enicostemma hyssopifolium. J Complement Integr Med. 6:1.
   Google Scholar
• Rajalingam R, Srinivasan N, Govindarajulu P. 1993. Effects of alloxan induced diabetes on lipid profiles in renal cortex and medulla of mature albino rats. Indian J Exp Biol. 31:577–579.
   PubMedGoogle Scholar
• Ridhay A, Noor A, Soekamto NH, Harlim T, van Altena I. 2012. A stigmasterol glycoside from the root wood of Melochia umbellata (Houtt) Stapf var. degrabrata K. Indones J Chem. 12:100–103.
   Google Scholar
• Robinson KM, Begovic ME, Rhinehart BL, Heineke EW, Ducep JB, Kastner PR, Marshall FN, Danzin C. 1991. New potent alpha-glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes. 40:825–830.
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. 2002. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 288:2579–2588.
   PubMed Web of Science ®Google Scholar
• Shirwaikar A, Rajendran K, Punitha IS. 2005. Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin-nicotinamide induced type 2 diabetic rats. J Ethnopharmacol. 97:369–374.
   PubMed Web of Science ®Google Scholar
• Yabe-Nishimura C. 1998. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 50:21–33.
   PubMed Web of Science ®Google Scholar